Eventide Healthcare & Life Sciences A (ETAHX) Research
Under typical market conditions, this fund commits a substantial portion—at least 80%—of its total investable capital (net assets plus any borrowed funds for investment) to equity and equity-linked instruments. These holdings specifically target companies within the healthcare and life sciences sectors, encompassing a range of securities such as common shares, preferred stock, options, and convertible debt. Furthermore, the fund possesses the flexibility to acquire stakes in companies domiciled outside the United States, without any geographical restrictions. This can be done either directly or through American Depositary Receipts (ADRs). Its investment mandate also allows for the inclusion of companies across the entire spectrum of market capitalizations, from small-cap to large-cap firms.
Market snapshot
- Symbol
- ETAHX
- Price
- $49.74
- Day change
- +1.26%
- Market cap
- $1.6B
- 52-week range
- 32.42-52.23
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Acadian Emerging Markets Investor (AEMGX)
- Acadian Emerging Markets Portfolio Class I (AEMZX)
- American Century One Choice 2045 Portfolio - I Class (AOOIX)
- American Century One Choice 2045 Portfolio Investor Class (AROIX)
- American Century One Choice 2025 Portfolio Investor Class (ARWIX)
- Columbia Capital Allocation Aggressive Portfolio Institutional 3 Class (CPDIX)
- Eventide Dividend Opportunities A (ETADX)
- Eventide Healthcare & Life Sciences Fd Cl N (ETNHX)
Open Eventide Healthcare & Life Sciences A (ETAHX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.